Testosterone 5 mg / Estriol 1 mg Rapid Dissolve Tablet (RDT) is a dual-hormone therapy option for women, combining bioidentical testosterone and estriol in a sublingual rapid dissolve tablet. When appropriate, this compounded formulation may be prescribed by a licensed provider to support individualized hormone therapy based on clinical evaluation and laboratory results. Each therapy order is dispensed as a 60-tablet supply, with dosing determined by the prescribing provider based on individual clinical needs.

FDA Update: The FDA has removed the boxed warning related to cardiovascular risk for testosterone therapy when appropriately prescribed and monitored by a licensed healthcare provider.

This compounded rapid dissolve tablet (RDT) combines bioidentical testosterone and estriol, designed to support hormone balance, energy, mood, and vaginal and urogenital health in women. Delivered in a convenient sublingual format, this therapy offers enhanced absorption and can be used as part of a personalized hormone replacement protocol under the supervision of a licensed medical provider. Important Information & Disclaimer: Compounded drug products are not evaluated by the FDA for safety or effectiveness. Always consult your licensed provider for individualized advice.

Important: Compounded medications are not FDA-approved for safety, efficacy, or quality. Always consult your licensed healthcare provider to determine whether hormone therapy is appropriate for you.

Testosterone Replacement Therapy

NAD+ Therapy

Gonadorelin Therapy

Kyzatrex: Oral Testosterone Replacement Therapy